Johns Hopkins to host International Planning Conference for Global AIDS and Health Fund

October 30, 2001

As United Nations members struggle to address the global AIDS pandemic, the Johns Hopkins University Center for AIDS Research is hosting a two-day conference for the world's public health and HIV experts to develop the blueprint for controlling AIDS and other epidemic infectious diseases. Attendees at the Hopkins conference, Oct. 30-31, are expected to determine the most feasible and cost-effective strategies for using the $1.5 billion Global AIDS and Health Fund in the developing world.

"One and a half billion dollars may sound like a lot, but it's only one-tenth the estimated need. The Fund must be used effectively if there is an expectation for an increase in the commitment," says John G. Bartlett, M.D., director of the Center for AIDS research and chief of the Division of Infectious Diseases at Hopkins. Hopkins has the world's largest HIV and AIDS research enterprise, with over $80 million per year in grants and 11 large HIV programs in the developing world.

The Global Fund to Fight AIDS, Tuberculosis and Malaria, an initiative of United Nations Secretary-General and Nobel laureate Kofi Annan, is expected to be in operation by the end of this year. To date, the fund comprises commitments from governments, foundations and individuals, according to the U.N.

A main objective of the two-day conference is to provide an evidence-based briefing document on methods "to decrease the epidemic in developing countries using available, feasible and cost-effective technologies," said Dr. Chrispis Kiyonga, National Political Commisar of Uganda and chair of the transitional working group for establishing the fund, in a written brief to conference organizers.

"The emphasis will be on methods to better control the epidemic and the quality and relevance of the science that supports these methods," said Bartlett. The conference will focus on five broad themes of prevention and treatment of HIV/AIDS, tuberculosis and malaria, including therapeutic and preventive vaccines; behavioral interventions, voluntary testing, and counseling; provision of anti-retroviral therapy; prevention of mother-to-child transmission; and prevention and treatment of opportunistic infections, including tuberculosis, and palliative care. The impact of interventions on the future course of the global AIDS epidemic and economic considerations will also be a topic of discussion.

Sponsors of the conference include the Center for AIDS Research, JHPIEGO, the Center for Communication Programs, and the Fogarty AIDS International Training and Research Program of Johns Hopkins University, the NIH Office of AIDS Research (OAR), and the Bristol-Myers Squibb Company.

Related Web Sites:

Johns Hopkins AIDS Service:
Joint United Nations Programme on HIV/AIDS:
AIDS-HIV Resource Center:

Media Contacts :
Trent Stockton

Gary Stephenson

Johns Hopkins Medical Institutions' news releases are available on an EMBARGOED basis on EurekAlert at, and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to

On a POST-EMBARGOED basis find them at

[The conference itself is not open to the press. John Bartlett, M.D., and other Hopkins experts on HIV/AIDS will be available for comment after the conference. For more information about the conference or to speak with Dr. Bartlett, call Trent Stockton at 410-955-8665, or Gary Stephenson at 410-955-5384.]

Johns Hopkins Medicine

Related Tuberculosis Articles from Brightsurf:

Scientists find new way to kill tuberculosis
Scientists have discovered a new way of killing the bacteria that cause tuberculosis (TB), using a toxin produced by the germ itself.

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.

Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.

Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.

A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.

How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.

Read More: Tuberculosis News and Tuberculosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to